ChronosDx
Implantable ultra-sensitive biosensing on a chip.
ChronosDx’s organic semiconductor sensor chip delivers real-time biomarker detection at point-of-care, offering unprecedented sensitivity and rapid results in a compact, implantable format—streamlining early disease diagnosis.
Founders
Ella Mi
Founding CEO
Ella is a medical oncologist from the University of Oxford, with 10 years research in early cancer detection. She has 7 years industry experience in the commercialisation and regulation of medical devices, as well as in drug trials for neurological diseases at a global pharmaceutical.